SC

Sandra Chennoufi

Clinical Development And Medical Affairs Director at Teoxane Laboratories

Sandra Chennoufi has a strong background in the clinical research field. Sandra has worked at several prominent pharmaceutical and healthcare companies throughout their career. Their most recent position was at Teoxane Laboratories, where they served as the Clinical Development and Medical Affairs Director. Prior to that, they held various roles at IQVIA, Advanced Accelerator Applications, and Genexion SA, where they gained experience as a Clinical Project Manager and Director of Global Program Management. Before entering the industry, Sandra worked as a Research Scientist at Nestle, where they managed scientific projects related to identifying and designing ingredient cocktails with anti-allergic properties. Overall, Sandra Chennoufi has a wealth of experience in clinical research and a proven track record in management and leadership roles.

Sandra Chennoufi pursued their education in a systematic manner, focusing on food science and technology. Starting in 1992, they attended Université Laval for seven years, completing their MSc in Food Science and Technology in 1999. Continuing their academic journey, they enrolled at ETH Zürich in 2000 for three years, where they earned their PhD in Food Microbiology in 2003. Throughout their education, Sandra Chennoufi's primary interests revolved around the study of food and its various aspects.

Location

Geneva, Switzerland

Links

Previous companies


Org chart


Teams


Offices


Teoxane Laboratories

1 followers

When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.